bioRxivImmunologyPreprint
Hepatitis C Virus E1 Protein Enhances Macrophage iNOS Expression In Vitro
B. Munkhjargal, B. Enkhtuvshin, U. Ulziisaikhan, B. Tuvdenjamts, K. Unurbuyan, D. Sandagdorj, B. Enkhjargal, T. Sandag, B. Tsolmon, E. Lkhagvasuren
Abstract
ObjectiveHepatitis C virus (HCV) is a single-stranded RNA virus that causes chronic hepatitis, cirrhosis, and liver cancer. Approximately 170 million individuals are infected with HCV worldwide. The pathogenesis of HCV-associated liver injury is thought to be due to the host antiviral immune response, including the T cell response, and excessive production of proinflammatory cytokines, reactive oxygen species, and nitric oxide (NO). Interferon-{gamma} (IFN-{gamma}) is a key cytokine in the adaptive immune response that is primarily secreted from CD4+ T helper cells to induce cytotoxic T lymphocyte (CTL) cell response against HCV infection. Another important role of IFN-{gamma} is the activation of macrophages in the liver resulting in inhibition of viral replication and increased NO production. Enhanced inducible nitric oxide synthase (iNOS) expression and NO production observed in the liver of HCV-infected patients is positively correlated with viral load and hepatic inflammation. HCV-infected macrophages are major producers of NO in the liver. It is not completely understood how HCV proteins affect iNOS expression and what the role of IFN-{gamma} is in HCV protein expression in HCV-infected macrophages. In this study, we examined the effect of INF-{gamma} and HCV proteins on iNOS expression in the Raw264.7 cell line. ResultsConsistent with other studies, HCV core and NS5A proteins induced iNOS expression in macrophages. Moreover, HCV E1 protein-enhanced iNOS expression is highest in the presence and absence of IFN-{gamma} activation. ConclusionThese results indicate that hepatitis C virus core, NS5A, E1 protein regulates iNOS protein expression in IFN-{gamma}-activated and resting macrophage cell lines. These findings points to a future research direction for understanding the pathogenesis of HCV-related liver inflammation.
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Removal of the C6 vaccinia virus interferon-β inhibitor in the hepatitis C vaccine candidate MVA-HCV elicited in mice high immunogenicity in spite of reduced host gene expression
M. Q. Marin, P. Perez, … J. Garcia-Arriaza·bioRxiv·May 25, 2018
- Inhibition of Nrf1 activity is a relevant for the HCV-dependent dysregulation of host lipid metabolism
Olga Szostek, Patrycja Schorsch, … Eberhard Hildt·bioRxiv·Aug 9, 2026
- IFN-{lambda}4 may contribute to HCV persistence by increasing ER stress and enhancing IRF1 signaling
O. O. Onabajo, F. Wang, … L. Prokunina-Olsson·bioRxiv·Oct 28, 2020
- The cell cycle regulator Cyclin E1 drives macrophage-associated inflammatory responses in acute immune-mediated hepatitis
Christian Penners, Cheng Lin, … Christian Liedtke·bioRxiv·Oct 1, 2026
- Hepatitis E virus infection upregulates ING5 expression in vitro and vivo
Wanqiu Zhao, Yueping Xia, … Fen Huang·Acta Biochimica et Biophysica SinicaPeer-reviewed·Jun 14, 2024
- HIV-1 Unspliced RNA Expression Induces Innate Immune Activation in Macrophages
Hisashi Akiyama, Caitlin M. Miller, … Suryaram Gummuluru·bioRxiv·Aug 10, 2017